Halothane-induced hepatitis: 8 Case reports;Atteintes hepatiques à l'halothane. À propos de 8 cas

Tunisie Medicale

Volumn 81, Issue 11, 2003, Pages 874-878

  Daghfous, Riadh ^a   El Aïdli, Sihem ^a   Sfaxi, Mohamed ^a   Daghfous, M ^a   Kastalli, S ^a   Srairi S ^a   Loueslati, Mohamed Hédi ^a   Belkahia, Chalbi ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Fulminant hepatitis; Halothane; Hepatotoxicity

Indexed keywords

HALOTHANE; INHALATION ANESTHETIC AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CYTOLYSIS; DRUG EFFECT; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HEPATITIS; HUMAN; IATROGENIC DISEASE; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; LIVER TOXICITY; MALE; PATHOLOGY; TOXIC HEPATITIS;

ADULT; AGED; ANESTHETICS, INHALATION; FEMALE; HALOTHANE; HEPATITIS, TOXIC; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED;

EID: 0742305762     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bégaud B, Evreux J.C, Jouglard J et Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France. Thérapie 1985; 40: 111-118.
2. Danan G. Définition et méthode d'imputabilité des atteintes aiguës médicamenteuses. Conclusion d'une réunion de consensus. Gastroentérol. Clin. Biol. 1993; 17: 18-21.
3. Allen A.L and Metcalf D.W. A search for halothane liver complications. Anesth. Analg. 1964; 43: 159-162.
4. Brody G.L and Sweet R.B. Halothane anesthesia as a possible cause of massive hepatic necrosis. Anesthesiology 1963; 24: 29-37.
5. Baittiger LE, Daler E and Hallen B. Halothane induced liver damage: an analysis of the material reported to the Swedish adverse drug reaction committee. 1966-1973. Acta. Anesthesiol. Scand. 1976; 20: 40-46.
6. Elliatt R.H and Strumin L. Hepatotoxicity of volatile anesthetics. Br. J. Anesth. 1993; 70: 339-348.
7. Khan F.M, Schafner F and Popper H. Hepatitis after exposure to halothane. Ann. Int. Med. 1995; 82: 689-699.
8. Wrigt R, Chiooholn M, Lloyd B and al. Controlled prospective study of the effect on liver fonction of multiple exposures to halathane. Lancet 1975; 1: 814-820.
9. Marshall B.E, Longnecker D.E. Anesthėsiques gėnėraux. In Goodman and Gilman. Les bases pharmacologiques de l'utilisation des médicaments. Mc Graw Hill edition. 9ème édition. 1998. 311-335.
10. Benjamin S.B, Gokodman Z.D. Ishak K.G and al. The marphalogic spectrum of halothane-induced hepatic injury: analysis of 77 cases. Hepatology 1985; 5: 1163-1171.
11. Gesnon P et Duvalildestin P. Anesthésiques valatiles halagėnés. In Giroud J.P, Mathė G, Meynell G et Coll. Pharmacologie clinique: bases de la thérapeutique. Expansion scientifique française éditian. 2ème èdition. 1988. 901-915.
12. Atallah M.M, Geddes I.C. Metabalism of halothane during and after anasthesia in man. Br. J. Anaesth. 1973; 45: 464-469.
13. Corbett T. H, Ball G.L. Respiratory excretion of halothane after clinical and occupational exposure. Anesthesialagy 1973; 39: 342-345.
14. Cousins M.J, Mazze R.I. Methoxyflurane nephrotoxicity, a study of dose response in man. JAMA 1973; 225: 1611-1616.
15. Castell J.V. Allergy hepatitis: a drug-mediated argan-specific immune reaction. Clin. Exp. Allergy 1998; 28 (4): 13-19.